Next Meetings

October 19, 2017 TBD

California Endowment Oakland Conference Center
2000 Franklin St.
Oakland, CA, 94612

ICER will review evidence on the comparative clinical effectiveness and value of certain cognitive and mind-body interventions for chronic low back and neck pain.

Register or Register for the Live Webcast

Tardive Dyskinesia

New England CEPAC

The New England CEPAC will convene to review ICER's evidence report assessing the clinical effectiveness and value of therapies to treat tardive dyskinesia, a movement disorder related to prolonged use of antipsychotic medications.

Voretigene Neparvovec

Midwest CEPAC
January 25, 2018 10am-4pm CT


The Midwest CEPAC will convene to deliberate on ICER's report on voretigene neparvovec.

March 2, 2018 10am-4pm PT

California, TBD

The California Technology Assessment Forum will convene to discuss evidence on CAR-T therapies.

Hemophilia A

New England CEPAC
March 29, 2018 10am-4pm EST

Boston, MA

The New England CEPAC will convene to review the comparative clinical effectiveness and value of emicizumab for treatment of hemophilia A.

past Meetings

Sep 2017
Midwest CEPAC

May 2017

Orphan Drug Assessment and Pricing Summit

ICER hosted a multi-stakeholder policy summit to discuss methods for assessing the value of new drugs for rare conditions. The summit included discussion of how methods can be applied to recommend fair prices that reflect the value of orphan drugs to patients and the health system, to allow for broader insurance coverage for innovative new treatments.

Process for Public Comment
ICER's Final Meeting Report and Proposed Framework Changes document outlining modifications to its assessment process when applied to treatments for rare conditions is now open to public comment until September 25, 2017.